IP Library Granted Patent US 9,821,052
Granted Patent B2
US 9,821,052 · App. 13/388,033 · Granted Nov 21, 2017

Reverse genetics systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,821,052
App. No.
13/388,033
Granted
Nov 21, 2017
Kind
B2
Abstract

The invention provides various reverse genetics systems for producing segmented RNA viruses, wherein the systems do not require bacteria for propagation of all of their expression constructs.

Claims (13)

1. A non-bacterial DNA construct comprising a promoter and coding sequences for expressing at least two different genome segments of a segmented RNA virus, wherein the construct lacks both a bacterial origin of replication and a bacterial selection marker, wherein the at least two segments are selected from the group of segments consisting of PB2, PB1, PA, HA, NP, NA, M and NS, wherein the construct is linear, and, wherein the promoter is operatively linked for transcription in an eukaryotic host cell, wherein the eukaryotic host cell is a mammalian cell or avian cell.

2. A eukaryotic host cell comprising the non-bacterial construct of claim 1 .

3. A method for producing a segmented RNA virus, comprising a step of culturing a host cell of claim 2 such that expression of the RNA virus segments occurs to produce the virus.

4. The host cell of claim 2 , wherein the cell is a MDCK cell.

5. The non-bacterial DNA construct of claim 1 , wherein the coding sequences are for influenza virus A or B genome segments PB2, PB1, PA, NP, and NS.

6. A method for producing a segmented RNA virus, comprising

a) transfecting a host cell with the construct of claim 1 , and

b) culturing the host cell such that expression of the RNA virus segments occurs to produce the virus;

wherein the host cell is a mammalian or avian host cell.

7. A non-bacterial DNA construct comprising a promoter and coding sequences for expressing all eight genome segments of an influenza A or B virus, wherein the construct lacks both a bacterial origin of replication and a bacterial selection marker, wherein the promoter is operatively linked for transcription in an eukaryotic host cell, wherein the eukaryotic host cell is a mammalian cell or avian cell, and wherein the construct is linear.

8. A eukaryotic host cell comprising the non-bacterial construct of claim 7 .

9. A method for producing a segmented RNA virus, comprising a step of culturing a host cell of claim 8 such that expression of the RNA virus segments occurs to produce the virus.

10. The host cell of claim 8 , wherein the cell is a MDCK cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2016
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 039335/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2012
From: DORMITZER, PHILIP; MASON, PETER; FRANTI, MICHAEL
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 028379/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2012
From: NOVARTIS VACCINES & DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 028379/0616 →